Dupilumab-Induced Juvenile Dermatomyositis: A Rare Immune-Mediated Adverse Event (ACAAI 2026) - Oct 28, 2026 - Abstract #M040; Pres time: Nov 13, 2026; 05:45 PM - 06:00 PM; Location: Phoenix Convention Center • North Halls 4–6 (Lower Level); Monitor 2; No abstract available
Adverse events • Dermatomyositis • Immunology • Myositis
|